[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341823-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341823-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","proteomic-landscape-profiling-of-primary-prostate-cancer-reveals-a-16-protein-panel-for-prognosis-prediction","Proteomic landscape profiling of primary prostate cancer reveals a 16-protein panel for prognosis prediction","","Prostate cancer is the most common malignant tumor in men, yet prognosis indicators for predicting outcomes and guiding treatment remain limited. This study performs comprehensive proteomic profiling of 918 tissue specimens from 306 Chinese patients using data-independent acquisition mass spectrometry. It identifies over 10,000 proteins, defines three proteomic molecular subtypes, and develops a 16-protein panel that predicts biochemical recurrence across stages and ISUP grades, outperforming D’Amico risk classification and revealing NUDT5 and SEPTIN8 as functional targets.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/proteomic-landscape-profiling-of-primary-prostate-cancer-reveals-a-16-protein-panel-for-prognosis-prediction/341823/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/proteomic-landscape-profiling-of-primary-prostate-cancer-reveals-a-16-protein-panel-for-prognosis-prediction/341823.png","ImageObject",300,407,{"name":42,"@type":43},"Miles","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What proteomic approach is used in the study?","Question",{"text":63,"@type":64},"The study uses data-independent acquisition mass spectrometry (DIA-MS) to perform comprehensive proteomic profiling of prostate cancer tissue specimens.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many patients and tissue specimens are analyzed?",{"text":68,"@type":64},"The analysis includes 306 Chinese patients and 918 tissue specimens.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the study develop for prognosis prediction?",{"text":72,"@type":64},"It develops a 16-protein panel that effectively predicts biochemical recurrence (BCR) across different ISUP grades and pathological stages.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341823,1790564628,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":33,"preview_urls":145},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nProteomic landscape proﬁling of primary prostate cancer reveals a 16-protein panel for prognosis prediction  \nGraphical abstract  \nHighlights  \nAuthors  \nRui Sun, Jun A, Haolan Yu, ...,  \nTiannan Guo, Xu Gao, Chenghua Yang  \nCorrespondence  \n[guotiannan@westlake.edu.cn](guotiannan@westlake.edu.cn) (T.G.),  \n[gaoxu.changhai@foxmail.com](gaoxu.changhai@foxmail.com) (X.G.),  \n[Chenghua-yang@qq.com](Chenghua-yang@qq.com) (C.Y.)  \nIn brief  \nSun et al. perform a comprehensive proteomic proﬁling of 306 Chinese patients with prostate cancer (PCa) and develop a 16-protein panel that effectively predicts BCR for patients with PCa across different PCa stages. This study provides an effective prognosis prediction technique and potential therapeutic strategies for patients with PCa.  \nd Three molecular subtypes of PCa revealed by comprehensive proteomic analysis  \nd A 16-protein panel effectively predicts BCR for patients with PCa across different stages  \nd Inhibiting NUDT5 and SEPTIN8 suppresses the malignant features of PCa  \nSun et al., 2024, Cell Reports Medicine 5, 101679  \nAugust 20, 2024 ª 2024 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.xcrm.2024.101679](https://doi.org/10.1016/j.xcrm.2024.101679)  \nll  \nll  \nOPEN ACCESS  \nArticle  \nProteomic landscape proﬁling of primary prostate cancer reveals  \na 16-protein panel for prognosis prediction  \nRui Sun,1,2,3,4,11 Jun A,1,2,3,4,11 Haolan Yu,5,6,10,11 Yan Wang,5,8,11 Miaoxia He,8,11 Lingling Tan,9 Honghan Cheng,1,2,3,4 Jili Zhang,5 Yingrui Wang,1,2,3,4 Xiaochen Sun,5,6 Mengge Lyu,1,2,3,4 Min Qu,5 Lingling Huang,1,9 Zijian Li,5 Wenhui Zhang,5 Kunpeng Ma,1,2,3,4 Zhenyang Dong,5 Weigang Ge,9 Yun Zhang,5 Xuan Ding,2,3,4 Bo Yang,5 Jianguo Hou,5  \nChuanliang Xu,5,7 Linhui Wang,5,7 Yi Zhu,1,2,3,4 Tiannan Guo,1,2,3,4,* Xu Gao,5,7,* and Chenghua Yang5,7,12,*  \n1School of Medicine, Westlake University, Hangzhou, Zhejiang Province, China  \n2Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang Province 310030, China  \n3Research Center for Industries of the Future, Westlake University, 600 Dunyu Road, Hangzhou, Zhejiang 310030, China  \n4Afﬁliated Hangzhou First People’s Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, China  \n5Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China  \n6CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China  \n7Shanghai Key Laboratory of Cell Engineering, Shanghai 200433, China  \n8Department of Pathology, Changhai Hospital, Second Military Medical University, Shanghai, China  \n9Westlake Omics (Hangzhou) Biotechnology Co. , Ltd. , Hangzhou 310024, China  \n10Present address: Institute of Cancer Research, Shenzhen Bay Laboratory, Shenzhen, China  \n11These authors contributed equally  \n12Lead contact  \n*Correspondence: [guotiannan@westlake.edu.cn](guotiannan@westlake.edu.cn) (T.G.), [gaoxu.changhai@foxmail.com](gaoxu.changhai@foxmail.com) (X.G.), [Chenghua-yang@qq.com](Chenghua-yang@qq.com) (C.Y.) [https://doi.org/10.1016/j.xcrm.2024.101679](https://doi.org/10.1016/j.xcrm.2024.101679)  \nSUMMARY  \nProstate cancer (PCa) is the most common malignant tumor in men. Currently, there are few prognosis indicators for predicting PCa outcomes and guiding treatments. Here, we perform comprehensive proteomic proﬁling of 918 tissue specimens from 306 Chinese patients with PCa using data-independent acquisition mass spectrometry (DIA-MS) . We identify over 10,000 proteins and deﬁne three molecular subtypes of PCa with signiﬁcant clinical and proteomic differences. We develop a 16-protein panel that effectively predicts biochemical recurrence (BCR) for patients with PCa, which is validated in six published datasets and one additional 99-biopsy-sample","cbCaihkVsTv6tSY2","https://ap.wps.com/l/cbCaihkVsTv6tSY2","pdf",6424092,24,"English","# Summary\n# Introduction","[{\"question\":\"What proteomic approach is used in the study?\",\"answer\":\"The study uses data-independent acquisition mass spectrometry (DIA-MS) to perform comprehensive proteomic profiling of prostate cancer tissue specimens.\"},{\"question\":\"How many patients and tissue specimens are analyzed?\",\"answer\":\"The analysis includes 306 Chinese patients and 918 tissue specimens.\"},{\"question\":\"What does the study develop for prognosis prediction?\",\"answer\":\"It develops a 16-protein panel that effectively predicts biochemical recurrence (BCR) across different ISUP grades and pathological stages.\"}]","Proteomic landscape profiling of primary prostate cancer reveals a 16-protein panel for prognosis prediction | PDF",1790043987,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca3e7258c5aa72ef66e488884abcdba2.webp",983,1276,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b81a4e083b00b451cc46e4862533d62d.webp",982,1275,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b7301ab9e5e2c063d0404b01fb538d3.webp",981,1273,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7bac00d7ba0380cd0d6422e6d62ae2a.webp",980,1272]